Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Trigger Point Extracorporeal Shock Wave Therapy in Patients With Lateral Epicondylitis

NCT: NCT07638488 · COMPLETED

NCT IDNCT07638488
StatusCOMPLETED
Start Date2024-10-21
Completion2026-06-24
SponsorGazi University (OTHER)
First posted
Last updated

Brief Summary

This randomized controlled study evaluates the effect of extracorporeal shock wave therapy applied to the extensor carpi radialis brevis trigger point in patients with lateral epicondylitis. Participants receive active extracorporeal shock wave therapy to the lateral epicondyle region. In addition, one group receives active extracorporeal shock wave therapy to the extensor carpi radialis brevis trigger point, while the other group receives sham extracorporeal shock wave therapy to the trigger point. Pain, grip strength, hand function, and common extensor tendon thickness are assessed before treatment and at week 4.

Frequently Asked Questions

What is Trigger Point Extracorporeal Shock Wave Therapy in Patients With Lateral Epicondylitis?

Trigger Point Extracorporeal Shock Wave Therapy in Patients With Lateral Epicondylitis is a clinical trial registered under NCT07638488. Current status: COMPLETED.

What is the status of NCT07638488?

The current status of NCT07638488 (Trigger Point Extracorporeal Shock Wave Therapy in Patients With Lateral Epicondylitis) is: COMPLETED.

When did Trigger Point Extracorporeal Shock Wave Therapy in Patients With Lateral Epicondylitis start?

Trigger Point Extracorporeal Shock Wave Therapy in Patients With Lateral Epicondylitis started on 2024-10-21.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.